Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis.
Pedro Santos-MorenoNelson J Alvis-ZakzukEdwin CastilloLaura VillarrealCarlos Javier Pineda-VillaseñorHugo SandovalOmaira ValenciaPublished in: ClinicoEconomics and outcomes research : CEOR (2021)
An alternative diagnosis process, including X-rays, US and MRI imaging, and clinical and blood-test assessment, not only increased diagnostic certainty in patients referred for evaluation of presumptive SRA but also suggested a potential cost-savings in pharmacological treatments avoided in misdiagnosed patients.
Keyphrases
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- high resolution
- prognostic factors
- peritoneal dialysis
- magnetic resonance
- patient reported outcomes
- computed tomography
- mass spectrometry
- risk assessment
- systemic lupus erythematosus
- idiopathic pulmonary fibrosis
- climate change
- ankylosing spondylitis
- fluorescence imaging